Editas Medicine (EDIT) EBIT Margin (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 111,514.00 |
| Jun 30, 2025 | 19,452.00 |
| Mar 31, 2025 | -148,286.00 |
| Dec 31, 2024 | 10.75 Mn |
| Sep 30, 2024 | -9.36 Mn |
| Jun 30, 2024 | -811,389.00 |
| Mar 31, 2024 | -586,239.00 |
| Dec 31, 2023 | 90,018.00 |
| Sep 30, 2023 | 58,724.00 |
| Jun 30, 2023 | -101,001.00 |
| Mar 31, 2023 | 45,340.00 |
| Dec 31, 2022 | 13.60 Mn |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | -10,295.00 |
| Mar 31, 2022 | -41,581.00 |
| Dec 31, 2021 | 29,971.00 |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | -1.37 Mn |
| Mar 31, 2021 | -29,839.00 |
| Dec 31, 2020 | -59,117.00 |
| Sep 30, 2020 | 30,586.00 |
| Jun 30, 2020 | 52,299.00 |
| Mar 31, 2020 | -49,362.00 |
| Dec 31, 2019 | 57,794.00 |
| Sep 30, 2019 | 63,114.00 |
| Jun 30, 2019 | -1,903.00 |
| Mar 31, 2019 | -108,193.00 |
| Dec 31, 2018 | -31,706.00 |
| Sep 30, 2018 | 42,596.00 |
| Jun 30, 2018 | 26,570.00 |
| Sep 30, 2017 | 41,743.00 |
| Jun 30, 2017 | 364,753.00 |
| Mar 31, 2017 | -14,956.00 |
| Dec 31, 2016 | -214,110.00 |
| Sep 30, 2016 | -163,340.00 |
| Jun 30, 2016 | 164,932.00 |
| Mar 31, 2016 | -65,378.00 |
| Dec 31, 2015 | -46,046.00 |
| Sep 30, 2015 | 512,336.00 |